• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PPARs 在衰老和长寿中的作用。

The Functions of PPARs in Aging and Longevity.

机构信息

Department of Internal Medicine, Faculty of Medicine, Celal Bayar University,45020 Manisa, Turkey.

出版信息

PPAR Res. 2007;2007:39654. doi: 10.1155/2007/39654.

DOI:10.1155/2007/39654
PMID:18317516
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2254525/
Abstract

Peroxisome proliferator-activated receptors (PPARs) are key regulators in various age-associated pathophysiological processes related to energy metabolism and oxidative stress. A progressive rise of oxidative stress and related inflammatory reaction appears the hallmarks of the aging process and many age-related diseases. PPARs are important redox-sensitive transcription factors and their dyregulated activations seem to be major culprits for these pathological processes. Drugs targeting PPARs activity are already in widespread clinical use; however, based on these concepts, this review highlights the understanding of the role of PPARs in aging and indicates the necessary particular attention for the potential therapeutic uses of current PPAR agonists in age-associated diseases.

摘要

过氧化物酶体增殖物激活受体 (PPARs) 是与能量代谢和氧化应激相关的各种与年龄相关的病理生理过程中的关键调节因子。氧化应激的逐渐增加和相关的炎症反应似乎是衰老过程和许多与年龄相关的疾病的特征。PPARs 是重要的氧化还原敏感转录因子,其活性失调似乎是这些病理过程的主要罪魁祸首。针对 PPAR 活性的药物已广泛应用于临床;然而,基于这些概念,本综述强调了 PPAR 在衰老中的作用,并指出了当前 PPAR 激动剂在与年龄相关的疾病中的潜在治疗用途所需的特别关注。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4ea/2254525/7fc9fc6eef21/PPAR2007-39654.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4ea/2254525/876d9c9145ca/PPAR2007-39654.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4ea/2254525/7fc9fc6eef21/PPAR2007-39654.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4ea/2254525/876d9c9145ca/PPAR2007-39654.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4ea/2254525/7fc9fc6eef21/PPAR2007-39654.002.jpg

相似文献

1
The Functions of PPARs in Aging and Longevity.PPARs 在衰老和长寿中的作用。
PPAR Res. 2007;2007:39654. doi: 10.1155/2007/39654.
2
Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism.过氧化物酶体增殖物与过氧化物酶体增殖物激活受体(PPARs)作为脂质代谢的调节因子。
Biochimie. 1997 Feb-Mar;79(2-3):81-94. doi: 10.1016/s0300-9084(97)81496-4.
3
Biology and therapeutic applications of peroxisome proliferator- activated receptors.过氧化物酶体增殖物激活受体的生物学和治疗应用。
Curr Top Med Chem. 2012;12(6):548-84. doi: 10.2174/156802612799436669.
4
The Role of PPARs in Pathological Cardiac Hypertrophy and Heart Failure.过氧化物酶体增殖物激活受体在病理性心肌肥大和心力衰竭中的作用
Curr Pharm Des. 2017;23(11):1677-1686. doi: 10.2174/1381612822666160928150040.
5
Peroxisome Proliferator-Activated Receptors and Their Agonists in Nonalcoholic Fatty Liver Disease.过氧化物酶体增殖物激活受体及其激动剂在非酒精性脂肪性肝病中的作用
J Clin Exp Hepatol. 2019 Nov-Dec;9(6):731-739. doi: 10.1016/j.jceh.2019.06.004. Epub 2019 Jul 2.
6
Modulation of PPAR in aging, inflammation, and calorie restriction.过氧化物酶体增殖物激活受体(PPAR)在衰老、炎症和热量限制中的调节作用
J Gerontol A Biol Sci Med Sci. 2004 Oct;59(10):997-1006. doi: 10.1093/gerona/59.10.b997.
7
Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the 'future' in dermatology therapeutics?过氧化物酶体增殖物激活受体(PPARs)与PPAR激动剂:皮肤病治疗的“未来”?
Arch Dermatol Res. 2015 Nov;307(9):767-80. doi: 10.1007/s00403-015-1571-1. Epub 2015 May 19.
8
Role of redox-regulated transcription factors in inflammation, aging and age-related diseases.
Exp Gerontol. 2000 Aug;35(5):521-32. doi: 10.1016/s0531-5565(00)00118-2.
9
[Role of the peroxisome proliferator-activated receptors (PPARS) in the regulation of lipids and inflammation control].过氧化物酶体增殖物激活受体(PPARS)在脂质调节和炎症控制中的作用
J Soc Biol. 2002;196(1):47-52.
10
PPARs as Nuclear Receptors for Nutrient and Energy Metabolism.过氧化物酶体增殖物激活受体作为营养和能量代谢的核受体。
Molecules. 2019 Jul 12;24(14):2545. doi: 10.3390/molecules24142545.

引用本文的文献

1
Exercise-Induced Muscle-Fat Crosstalk: Molecular Mediators and Their Pharmacological Modulation for the Maintenance of Metabolic Flexibility in Aging.运动诱导的肌肉-脂肪相互作用:分子介质及其药理学调节对维持衰老过程中代谢灵活性的作用
Pharmaceuticals (Basel). 2025 Aug 19;18(8):1222. doi: 10.3390/ph18081222.
2
Adipose Factor ANGPTL4: Its Role in Aging Mechanisms and Associated Diseases.脂肪因子ANGPTL4:其在衰老机制及相关疾病中的作用
Clin Interv Aging. 2025 Jun 28;20:911-929. doi: 10.2147/CIA.S522049. eCollection 2025.
3
Deciphering aging-associated molecular mechanisms in bone marrow derived hematopoietic stem cells in the elderly using NGS data.

本文引用的文献

1
Homo obesus: a metabotrophin-deficient species. Pharmacology and nutrition insight.肥胖人类:一种代谢营养因子缺乏的物种。药理学与营养洞察。
Curr Pharm Des. 2007;13(21):2176-9. doi: 10.2174/138161207781039616.
2
Insulin resistance is an evolutionarily conserved physiological mechanism at the cellular level for protection against increased oxidative stress.胰岛素抵抗是一种在细胞水平上进化保守的生理机制,用于抵御氧化应激增加。
Bioessays. 2007 Aug;29(8):811-8. doi: 10.1002/bies.20618.
3
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.
利用二代测序(NGS)数据解析老年人骨髓来源造血干细胞中与衰老相关的分子机制。
Bioinformation. 2024 Feb 29;20(2):180-189. doi: 10.6026/973206300200180. eCollection 2024.
4
OMICs Signatures Linking Persistent Organic Pollutants to Cardiovascular Disease in the Swedish Mammography Cohort.OMICS 特征将持久性有机污染物与瑞典乳腺 X 线照相队列的心血管疾病联系起来。
Environ Sci Technol. 2024 Jan 16;58(2):1036-1047. doi: 10.1021/acs.est.3c06388. Epub 2024 Jan 4.
5
Effects of aging-induced obesity on the transcriptional expression of adipogenesis and thermogenic activity in the gonadal white adipose, brown adipose, and skeletal muscle tissues.衰老诱导的肥胖对性腺白色脂肪、棕色脂肪和骨骼肌组织中脂肪生成和产热活性转录表达的影响。
Phys Act Nutr. 2023 Jun;27(2):39-49. doi: 10.20463/pan.2023.0017. Epub 2023 Jun 30.
6
Partial inhibition of class III PI3K VPS-34 ameliorates motor aging and prolongs health span.部分抑制 III 类 PI3K VPS-34 可改善运动衰老并延长健康寿命。
PLoS Biol. 2023 Jul 11;21(7):e3002165. doi: 10.1371/journal.pbio.3002165. eCollection 2023 Jul.
7
Peroxisome Proliferator-Activated Receptor Alpha (PPAR-α) as a Regulator of the Angiogenic Profile of Endometriotic Lesions.过氧化物酶体增殖物激活受体α(PPAR-α)作为子宫内膜异位症病变血管生成特征的调节因子
Cureus. 2022 Feb 25;14(2):e22616. doi: 10.7759/cureus.22616. eCollection 2022 Feb.
8
RNA-seq analysis of phagocytic cells from murine epididymal white adipose tissue shows immunosenescence and age-related phosphorus metabolism.对鼠附睾白色脂肪组织中吞噬细胞的 RNA-seq 分析显示免疫衰老和与年龄相关的磷代谢。
Hum Cell. 2022 Mar;35(2):572-582. doi: 10.1007/s13577-021-00663-4. Epub 2022 Jan 15.
9
G protein-coupled receptors that influence lifespan of human and animal models.影响人类和动物模型寿命的 G 蛋白偶联受体。
Biogerontology. 2022 Feb;23(1):1-19. doi: 10.1007/s10522-021-09945-8. Epub 2021 Dec 3.
10
Transcriptomic and epigenomic profiling of young and aged spermatogonial stem cells reveals molecular targets regulating differentiation.转录组和表观基因组分析年轻和衰老的精原干细胞,揭示调节分化的分子靶标。
PLoS Genet. 2021 Jul 8;17(7):e1009369. doi: 10.1371/journal.pgen.1009369. eCollection 2021 Jul.
罗格列酮对心肌梗死风险及心血管原因所致死亡的影响。
N Engl J Med. 2007 Jun 14;356(24):2457-71. doi: 10.1056/NEJMoa072761. Epub 2007 May 21.
4
Metabolic Functions of Peroxisome Proliferator-Activated Receptor beta/delta in Skeletal Muscle.过氧化物酶体增殖物激活受体-β/δ在骨骼肌中的代谢功能。
PPAR Res. 2007;2007:86394. doi: 10.1155/2007/86394.
5
PPARs, Obesity, and Inflammation.过氧化物酶体增殖物激活受体(PPARs)、肥胖与炎症
PPAR Res. 2007;2007:95974. doi: 10.1155/2007/95974.
6
PPARs in Calorie Restricted and Genetically Long-Lived Mice.热量限制和遗传长寿小鼠中的 PPARs。
PPAR Res. 2007;2007:28436. doi: 10.1155/2007/28436.
7
Interleukin-6 (IL-6) is still the leading biomarker of the metabolic and aging related disorders.白细胞介素-6(IL-6)仍然是代谢和衰老相关疾病的主要生物标志物。
Med Hypotheses. 2007;69(3):708. doi: 10.1016/j.mehy.2007.01.021. Epub 2007 Mar 1.
8
Rosiglitazone induces decreases in bone mass and strength that are reminiscent of aged bone.罗格列酮会导致骨量和骨强度下降,这与衰老的骨骼情况相似。
Endocrinology. 2007 Jun;148(6):2669-80. doi: 10.1210/en.2006-1587. Epub 2007 Mar 1.
9
Diabetes, TZDs, and Bone: A Review of the Clinical Evidence.糖尿病、TZDs 和骨骼:临床证据综述。
PPAR Res. 2006;2006:24502. doi: 10.1155/PPAR/2006/24502.
10
Aging results in paradoxical susceptibility of fat cell progenitors to lipotoxicity.衰老导致脂肪细胞祖细胞对脂毒性产生矛盾的易感性。
Am J Physiol Endocrinol Metab. 2007 Apr;292(4):E1041-51. doi: 10.1152/ajpendo.00557.2006. Epub 2006 Dec 5.